Evidence map›Paper›PMID 29568443›Full record

ArticleChemical science2017

A modular route to boron doped PAHs by combining borylative cyclisation and electrophilic C-H borylation.

D L Crossley, R J Kahan, S Endres, A J Warner, R A Smith, J Cid, J J Dunsford, J E Jones, I Vitorica-Yrezabal, M J Ingleson

Abstract read
In one paragraph

Article in Chemical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Metal-Free Electrophilic Borylative Cyclizations of Alkynes.Chemical record (New York, N.Y.) · 2026
    Review
  2. Article
  3. Stable BFAngewandte Chemie (International ed. in English) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Highly emissive planarizedRSC advances · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

D L CrossleySchool of Chemistry , University of Manchester , Manchester , M13 9PL , UK . Email: Michael.ingleson@manchester.ac.uk.
R J KahanSchool of Chemistry , University of Manchester , Manchester , M13 9PL , UK . Email: Michael.ingleson@manchester.ac.uk.ORCID 0000-0002-1171-4936
S EndresSchool of Chemistry , University of Manchester , Manchester , M13 9PL , UK . Email: Michael.ingleson@manchester.ac.uk.
A J WarnerSchool of Chemistry , University of Manchester , Manchester , M13 9PL , UK . Email: Michael.ingleson@manchester.ac.uk.
R A SmithSchool of Chemistry , University of Manchester , Manchester , M13 9PL , UK . Email: Michael.ingleson@manchester.ac.uk.
J CidSchool of Chemistry , University of Manchester , Manchester , M13 9PL , UK . Email: Michael.ingleson@manchester.ac.uk.ORCID 0000-0003-4579-7909
J J DunsfordSchool of Chemistry , University of Manchester , Manchester , M13 9PL , UK . Email: Michael.ingleson@manchester.ac.uk.
J E JonesSchool of Chemistry , University of Manchester , Manchester , M13 9PL , UK . Email: Michael.ingleson@manchester.ac.uk.
I Vitorica-YrezabalSchool of Chemistry , University of Manchester , Manchester , M13 9PL , UK . Email: Michael.ingleson@manchester.ac.uk.
M J InglesonSchool of Chemistry , University of Manchester , Manchester , M13 9PL , UK . Email: Michael.ingleson@manchester.ac.uk.ORCID 0000-0001-9975-8302

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heteroatom doping into polyaromatic hydrocarbons (PAHs) is a powerful approach for modifying key physical properties, however, there are extremely few modular routes that enable facile formation of B-, B

Identifiers

PMID29568443
PMCPMC5853289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.